Long Pentraxin 3 Measured at Late Phase Associated with GRACE Risk Scores in Patients with Non ST Elevation Acute Coronary Syndrome Underwent Coronary Stenting
| Autor: | Ertugrul Ercan, Gülden Sönmez Tamer, Istemihan Tengiz, Hicran Yıldız, Serkan Saygi, Nurullah Tuzun, Emin Alioglu, Uğur Önsel Türk, Bahadır Kırılmaz |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Adult
Male Acute coronary syndrome medicine.medical_specialty medicine.medical_treatment Risk Assessment Angina Percutaneous Coronary Intervention Diabetes mellitus Internal medicine medicine Humans Angina Stable Myocardial infarction Acute Coronary Syndrome Aged business.industry ST elevation Percutaneous coronary intervention Coronary stenting Middle Aged Prognosis medicine.disease Serum Amyloid P-Component C-Reactive Protein Linear Models Cardiology Female Stents Cardiology and Cardiovascular Medicine Risk assessment business |
| Zdroj: | Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology. 40:205-212 |
| ISSN: | 1016-5169 |
| DOI: | 10.5543/tkda.2012.90083 |
| Popis: | Objectives We analyzed pentraxin 3 (PTX3) levels and the relation of PTX3 levels with GRACE risk scores in 39 patients with non-ST elevation acute coronary syndrome (ACS) and stabile angina after stenting. Study design Seventeen patients with ACS and 22 patients with stabile angina who underwent coronary stenting were included in the study. PTX3 levels were measured serially at admission, at the 8th hour and at the 24th hour after stenting. Results While diabetes and hypertension were more frequent in the stabile angina group, leukocyte counts were significantly higher in the ACS group. PTX3 levels measured at the 8th hour were significantly higher in the ACS group compared to the stabile angina group (p=0.003). Strong correlations were observed between 24th hour PTX3 levels and GRACE scores calculated for risk of death and death/MI at admission (in-hospital/to 6 months), and for risk of death/MI at discharge to 6 months (R=0.571, p=0.01, R=0.564, p=0.01; R=0.558, p=0.02, R=0.512, p=0.03; R=0.653, p=0.004, respectively). Conclusion The serum PTX3 levels may provide important information for the early risk stratification of patients with ACS who underwent coronary stenting. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|